Navigation Links
Clinical Trial by Licensee Does Not Meet Primary Endpoint
Date:7/30/2009

PASADENA, Calif., July 30 /PRNewswire-FirstCall/ -- AutoImmune Inc. (OTC Bulletin Board: AIMM) today announced its licensee, BioMS Medical Corp., and Eli Lilly and Company reported that dirucotide did not meet the primary endpoint of delaying disease progression, as measured by the Expanded Disability Status Scale (EDSS), during the two-year Phase III trial in patients with secondary progressive multiple sclerosis (SPMS). In addition, there were no statistically significant differences between dirucotide and placebo on the secondary endpoints of the study. Lilly and BioMS also announced that they would discontinue ongoing clinical trials and review available data.

AutoImmune has exclusively licensed certain of its intellectual property rights to BioMS. Under the license agreement, BioMS makes monthly diligence payments to AutoImmune and will pay royalties to AutoImmune on sales of its lead drug, dirucotide, if it reaches the market.

Chairman of the Board and Chief Executive Officer Robert C. Bishop, Ph.D. stated, "We are obviously disappointed by the results and look forward to further announcements from BioMS and Lilly regarding their future plans for this approach to treating SPMS."

AutoImmune is a biopharmaceutical company involved in the development of treatments for autoimmune and cell-mediated inflammatory diseases and conditions.

Statements in this release that are not strictly historical are forward-looking statements including statements about clinical trials and studies and future sales, royalties and revenue. You can identify these forward-looking statements because they involve our expectations, beliefs, projections, anticipations or other characterizations of future events or circumstances. These forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that may cause actual results to differ
'/>"/>

SOURCE AutoImmune Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Are imaging features of hepatic angiomyolipoma related to its clinical setting?
2. Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillions Clinical Workstation Solution
3. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence at the American Podiatric Medical Association (APMA) Annual Scientific Meeting in Toronto, Canada
4. HOWARU(R) Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children
5. Sunshine Heart Provides C-Pulse U.S. Clinical Update
6. QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System
7. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
8. Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday, August 5, 2009
9. Male Fertility Supplement Improves Sperm Quality & Motility in Clinical Study
10. Lutonix, Inc. Announces First Patient Enrollments in Three Separate Clinical Trials
11. Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... ... A June 10, 2015 article from the News-Press, entitled " It's Never ... regular skin cancer screenings from an early age. Skin cancer can strike at any ... skin cancer is rarely fatal; however, if left alone for too long, the fatality ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... two patients in a Clinical Performance Study for the Invisiport at Wheaton Franciscan ... 6 French catheter options, offers a less invasive, patient-friendly alternative to traditional chest ...
(Date:7/29/2015)... ... July 29, 2015 , ... Attorneys representing American families in national talcum powder ... website now features a page dedicated to news related to pending talcum powder lawsuits, ... Talcum Powder Lawsuit News page was launched with eight initial articles. , “We ...
(Date:7/29/2015)... ... 29, 2015 , ... The New Foundation AZ recently started a ... will cost the 501(c) organization nearly $1 million, will both update the facilities’ design ... took it down to the studs,” said Geraldine Leary, the New Foundation AZ chief ...
(Date:7/29/2015)... ... 29, 2015 , ... National non-profit World T.E.A.M. Sports announced ... employee benefits and asset management, has joined as presenting sponsor for the inaugural ... Charlotte, North Carolina on October 2-4, 2015. , Hosted at the U.S. ...
Breaking Medicine News(10 mins):Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3
... Physicians now have access to real time radiology ... Viewbox (patent pending) is a portable interface system ... specialist consultation to physicians using any internet-ready device. ... in transmitting patient information and offers a timely ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... can increase the risk of surgical site infections in ... long been aware that people with diabetes are more ... blood sugar and increased risk of infection after surgery ...
... imaging (MRI) may be sufficient for the routine surveillance of ... cavae]) stents that are commonly used to treat congenital heart ... great vessels that is present at birth) in children and ... of the American Journal of Roentgenology ( www.ajronline.org ...
... (JHS) will be observed on Sept. 23-24 in Jackson, ... to investigate genetic factors that affect high blood pressure, ... diseases in African-Americans. "Cardiovascular disease is ... United States. The Jackson Heart Study is exploring ...
... Reporter , MONDAY, Sept. 20 (HealthDay News) -- Annual flu shots ... a shot is given the greater the protection, a new British ... reduced by 19 percent for those who had a vaccination in ... and prehospital health care at the University of Lincoln. The ...
... in ten U.S. adolescents uses sunless tanning products, and ... regular tanning may reduce sunbathing and sunburns among adult ... of Archives of Dermatology , one of the ... to the highest cancer risk category and is the ...
Cached Medicine News:Health News:Virtual Viewbox offers portable radiology access for physicians 2Health News:High Blood Sugar Levels Increase Infection Risk From General Surgery 2Health News:High Blood Sugar Levels Increase Infection Risk From General Surgery 3Health News:MRI could be used for routine surveillance of great vessel stents 2Health News:NIH celebrates 10 years of research into health disparities 2Health News:Study Claims Flu Shots Associated With Lower Risk of Heart Attack 2Health News:Study Claims Flu Shots Associated With Lower Risk of Heart Attack 3Health News:Use of sunless tanning products common in teens, may encourage sun safety in women 2Health News:Use of sunless tanning products common in teens, may encourage sun safety in women 3
(Date:7/29/2015)... 29, 2015   Decision Resources Group finds ... Europe will continue to be hindered in ... Eurozone. On a longer timeline, however, the outlook is ... active will increase the prevalence of osteoarthritic damage and ... orthopedic soft tissue solutions. Coupled with continuing economic recovery ...
(Date:7/29/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider ... the Life Sciences sector, by setting up Intelent ... 3 million USD . Intelent aims to address the ... projections by McKinsey) by providing clients offerings in the areas ... Noting the exponential growth in ...
(Date:7/29/2015)... , July 29, 2015 Touro College has announced ... CanniCare,s application for one of five media marijuana licenses to ... Dept. of Health (DOH).  If CanniCare ... medicinal cannabis.  "Our college is supportive of ... president of the Touro College System. "There is still a ...
Breaking Medicine Technology:The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 3TAKE Solutions Creates a New Subsidiary for Life Sciences Big Data in the US 2TAKE Solutions Creates a New Subsidiary for Life Sciences Big Data in the US 3Touro College Announces Support for CanniCare's Medical Cannabis License Application 2
...   CVS Caremark,s MinuteClinic , the leading retail ... from its existing, proprietary Electronic Medical Record system ... This transition will assist MinuteClinic in its mission ... hundreds of retail clinics across the United States. ...
... ATLANTA, Feb. 21, 2012  Arbor Pharmaceuticals, a specialty ... that Leslie Zacks has joined the company as ... has a distinguished legal career and most recently ... Inc. (previously Sciele Pharma).  While at Shionogi, Leslie ...
Cached Medicine Technology:CVS Caremark's MinuteClinic to Deploy Allscripts EHR Nationally 2CVS Caremark's MinuteClinic to Deploy Allscripts EHR Nationally 3CVS Caremark's MinuteClinic to Deploy Allscripts EHR Nationally 4CVS Caremark's MinuteClinic to Deploy Allscripts EHR Nationally 5Leslie Zacks Joins Arbor Pharmaceuticals as General Counsel and Chief Compliance Officer 2
PulmoLife is a new COPD screening device, designed for quick and easy screening of adult smokers for early detection of COPD....
Custom Conjugation Services...
Colloidal Gold Conjugated, Rabbit anti-goat IgG (H&L) - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: